Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

GYRO vs WELL vs GMRE vs VTR vs CHCT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
GYRO
Gyrodyne, LLC

Real Estate - Services

Real EstateNASDAQ • US
Market Cap$17M
5Y Perf.-53.0%
WELL
Welltower Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$149.25B
5Y Perf.+320.4%
GMRE
Global Medical REIT Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$94M
5Y Perf.-35.4%
VTR
Ventas, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$41.15B
5Y Perf.+147.6%
CHCT
Community Healthcare Trust Incorporated

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$505M
5Y Perf.-51.5%

GYRO vs WELL vs GMRE vs VTR vs CHCT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
GYRO logoGYRO
WELL logoWELL
GMRE logoGMRE
VTR logoVTR
CHCT logoCHCT
IndustryReal Estate - ServicesREIT - Healthcare FacilitiesREIT - Healthcare FacilitiesREIT - Healthcare FacilitiesREIT - Healthcare Facilities
Market Cap$17M$149.25B$94M$41.15B$505M
Revenue (TTM)$3M$11.63B$148M$6.13B$122M
Net Income (TTM)$0.00$1.43B$2M$260M$6M
Gross Margin99.6%39.1%68.8%-4.3%62.8%
Operating Margin-1.2%4.4%24.9%13.4%31.3%
Forward P/E78.4x595.7x118.0x37.6x
Total Debt$0.00$21.38B$654M$13.22B$536M
Cash & Equiv.$3.05T$5.03B$7M$741M$3M

GYRO vs WELL vs GMRE vs VTR vs CHCTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

GYRO
WELL
GMRE
VTR
CHCT
StockMay 20May 26Return
Gyrodyne, LLC (GYRO)10047.0-53.0%
Welltower Inc. (WELL)100420.4+320.4%
Global Medical REIT… (GMRE)10064.6-35.4%
Ventas, Inc. (VTR)100247.6+147.6%
Community Healthcar… (CHCT)10048.5-51.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: GYRO vs WELL vs GMRE vs VTR vs CHCT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: WELL leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and recent price momentum and sentiment. Gyrodyne, LLC is the stronger pick specifically for profitability and margin quality. GMRE, VTR, and CHCT also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
GYRO
Gyrodyne, LLC
The Real Estate Income Play

GYRO is the #2 pick in this set and the best alternative if quality is your priority.

  • 99.6% margin vs GMRE's 1.7%
Best for: quality
WELL
Welltower Inc.
The Real Estate Income Play

WELL carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
  • 223.1% 10Y total return vs GMRE's 308.1%
  • Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
  • 35.8% FFO/revenue growth vs GMRE's -1.8%
Best for: growth exposure and long-term compounding
GMRE
Global Medical REIT Inc.
The Real Estate Income Play

GMRE ranks third and is worth considering specifically for income & stability.

  • Dividend streak 5 yrs, beta 0.48, yield 63.5%
  • 63.5% yield, 5-year raise streak, vs CHCT's 11.3%, (1 stock pays no dividend)
Best for: income & stability
VTR
Ventas, Inc.
The Real Estate Income Play

VTR is the clearest fit if your priority is defensive.

  • Beta 0.01, yield 2.1%, current ratio 0.96x
  • Beta 0.01 vs CHCT's 0.60, lower leverage
Best for: defensive
CHCT
Community Healthcare Trust Incorporated
The Real Estate Income Play

CHCT is the clearest fit if your priority is value.

  • Lower P/E (37.6x vs 118.0x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthWELL logoWELL35.8% FFO/revenue growth vs GMRE's -1.8%
ValueCHCT logoCHCTLower P/E (37.6x vs 118.0x)
Quality / MarginsGYRO logoGYRO99.6% margin vs GMRE's 1.7%
Stability / SafetyVTR logoVTRBeta 0.01 vs CHCT's 0.60, lower leverage
DividendsGMRE logoGMRE63.5% yield, 5-year raise streak, vs CHCT's 11.3%, (1 stock pays no dividend)
Momentum (1Y)WELL logoWELL+42.7% vs GMRE's +0.1%
Efficiency (ROA)WELL logoWELL2.3% ROA vs GMRE's 0.2%, ROIC 0.5% vs 2.0%

GYRO vs WELL vs GMRE vs VTR vs CHCT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

GYROGyrodyne, LLC

Segment breakdown not available.

WELLWelltower Inc.
FY 2025
Senior Housing - Operating
81.1%$8.5B
Triple Net
11.4%$1.2B
Outpatient Medical
7.5%$782M
GMREGlobal Medical REIT Inc.

Segment breakdown not available.

VTRVentas, Inc.
FY 2025
Senior Living Operations
74.0%$4.3B
Outpatient Medical And Research Portfolio
15.5%$898M
Triple Net Leased Properties
10.4%$602M
CHCTCommunity Healthcare Trust Incorporated
FY 2018
Real Estate
100.0%$6M

GYRO vs WELL vs GMRE vs VTR vs CHCT — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLWELLLAGGINGCHCT

Income & Cash Flow (Last 12 Months)

Evenly matched — GYRO and WELL and CHCT each lead in 2 of 6 comparable metrics.

WELL is the larger business by revenue, generating $11.6B annually — 4156.8x GYRO's $3M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to GMRE's 1.7%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricGYRO logoGYROGyrodyne, LLCWELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.CHCT logoCHCTCommunity Healthc…
RevenueTrailing 12 months$3M$11.6B$148M$6.1B$122M
EBITDAEarnings before interest/tax$176,211$2.8B$95M$2.3B$82M
Net IncomeAfter-tax profit$0$1.4B$2M$260M$6M
Free Cash FlowCash after capex$1.8B$2.5B$19M$1.4B$60M
Gross MarginGross profit ÷ Revenue+99.6%+39.1%+68.8%-4.3%+62.8%
Operating MarginEBIT ÷ Revenue-1.2%+4.4%+24.9%+13.4%+31.3%
Net MarginNet income ÷ Revenue+12.3%+1.7%+4.2%+5.0%
FCF MarginFCF ÷ Revenue+630.3%+21.9%+12.6%+22.4%+49.4%
Rev. Growth (YoY)Latest quarter vs prior year+40.3%+18.7%+22.0%+4.8%
EPS Growth (YoY)Latest quarter vs prior year+22.5%-166.2%0.0%+124.4%
Evenly matched — GYRO and WELL and CHCT each lead in 2 of 6 comparable metrics.

Valuation Metrics

Evenly matched — GYRO and GMRE and CHCT each lead in 2 of 6 comparable metrics.

At 115.3x trailing earnings, GMRE trades at a 50% valuation discount to CHCT's 228.4x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than WELL's 66.4x.

MetricGYRO logoGYROGyrodyne, LLCWELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.CHCT logoCHCTCommunity Healthc…
Market CapShares × price$17M$149.2B$94M$41.1B$505M
Enterprise ValueMkt cap + debt − cash-$3.05T$165.6B$741M$53.6B$1.0B
Trailing P/EPrice ÷ TTM EPS153.25x115.29x160.26x228.42x
Forward P/EPrice ÷ next-FY EPS est.78.42x595.67x118.01x37.62x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple-18355314.90x66.40x8.35x24.31x16.27x
Price / SalesMarket cap ÷ Revenue13.99x0.68x7.05x4.17x
Price / BookPrice ÷ Book value/share0.00x3.35x0.17x3.18x1.11x
Price / FCFMarket cap ÷ FCF52.41x31.25x8.95x
Evenly matched — GYRO and GMRE and CHCT each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

WELL leads this category, winning 4 of 9 comparable metrics.

WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $0 for GMRE. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to CHCT's 1.25x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs GYRO's 2/9, reflecting strong financial health.

MetricGYRO logoGYROGyrodyne, LLCWELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.CHCT logoCHCTCommunity Healthc…
ROE (TTM)Return on equity+3.5%+0.5%+2.1%+1.4%
ROA (TTM)Return on assets+2.3%+0.2%+1.0%+0.6%
ROICReturn on invested capital0.0%+0.5%+2.0%+2.5%+1.6%
ROCEReturn on capital employed0.0%+0.6%+5.3%+3.2%+2.8%
Piotroski ScoreFundamental quality 0–927465
Debt / EquityFinancial leverage0.49x1.18x1.05x1.25x
Net DebtTotal debt minus cash-$3.05T$16.3B$647M$12.5B$533M
Cash & Equiv.Liquid assets$3.05T$5.0B$7M$741M$3M
Total DebtShort + long-term debt$0$21.4B$654M$13.2B$536M
Interest CoverageEBIT ÷ Interest expense5.00x0.26x1.14x1.40x1.15x
WELL leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

WELL leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $5,441 for CHCT. Over the past 12 months, WELL leads with a +42.7% total return vs GMRE's +0.1%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs CHCT's -13.9% — a key indicator of consistent wealth creation.

MetricGYRO logoGYROGyrodyne, LLCWELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.CHCT logoCHCTCommunity Healthc…
YTD ReturnYear-to-date-18.2%+14.3%+6.9%+12.6%+11.2%
1-Year ReturnPast 12 months+0.1%+42.7%+0.1%+33.9%+14.5%
3-Year ReturnCumulative with dividends-12.1%+189.5%+5.6%+94.2%-36.1%
5-Year ReturnCumulative with dividends-43.0%+202.3%-21.4%+74.8%-45.6%
10-Year ReturnCumulative with dividends-31.6%+223.1%+308.1%+65.0%+83.9%
CAGR (3Y)Annualised 3-year return-4.2%+42.5%+1.8%+24.8%-13.9%
WELL leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

VTR leads this category, winning 2 of 2 comparable metrics.

VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than CHCT's 0.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs GYRO's 63.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricGYRO logoGYROGyrodyne, LLCWELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.CHCT logoCHCTCommunity Healthc…
Beta (5Y)Sensitivity to S&P 5000.33x0.13x0.48x0.01x0.60x
52-Week HighHighest price in past year$12.00$219.59$39.93$88.50$18.22
52-Week LowLowest price in past year$6.70$142.65$29.05$61.76$13.23
% of 52W HighCurrent price vs 52-week peak+63.0%+97.0%+89.5%+97.8%+97.0%
RSI (14)Momentum oscillator 0–10050.060.252.756.256.9
Avg Volume (50D)Average daily shares traded1K2.6M130K3.4M228K
VTR leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — GMRE and CHCT each lead in 1 of 2 comparable metrics.

Analyst consensus: WELL as "Buy", GMRE as "Buy", VTR as "Buy", CHCT as "Hold". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs 4.6% for CHCT (target: $19). For income investors, GMRE offers the higher dividend yield at 63.51% vs WELL's 1.30%.

MetricGYRO logoGYROGyrodyne, LLCWELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.CHCT logoCHCTCommunity Healthc…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHold
Price TargetConsensus 12-month target$226.50$40.00$90.80$18.50
# AnalystsCovering analysts34223216
Dividend YieldAnnual dividend ÷ price+1.3%+63.5%+2.1%+11.3%
Dividend StreakConsecutive years of raises425111
Dividend / ShareAnnual DPS$2.76$22.70$1.86$2.00
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%0.0%+0.4%
Evenly matched — GMRE and CHCT each lead in 1 of 2 comparable metrics.
Key Takeaway

WELL leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). VTR leads in 1 (Risk & Volatility). 3 tied.

Best OverallWelltower Inc. (WELL)Leads 2 of 6 categories
Loading custom metrics...

GYRO vs WELL vs GMRE vs VTR vs CHCT: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is GYRO or WELL or GMRE or VTR or CHCT a better buy right now?

For growth investors, Welltower Inc.

(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — GYRO or WELL or GMRE or VTR or CHCT?

On trailing P/E, Global Medical REIT Inc.

(GMRE) is the cheapest at 115. 3x versus Community Healthcare Trust Incorporated at 228. 4x. On forward P/E, Community Healthcare Trust Incorporated is actually cheaper at 37. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — GYRO or WELL or GMRE or VTR or CHCT?

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +202. 3%, compared to -45. 6% for Community Healthcare Trust Incorporated (CHCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus GYRO's -31. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — GYRO or WELL or GMRE or VTR or CHCT?

By beta (market sensitivity over 5 years), Ventas, Inc.

(VTR) is the lower-risk stock at 0. 01β versus Community Healthcare Trust Incorporated's 0. 60β — meaning CHCT is approximately 6216% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 125% for Community Healthcare Trust Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — GYRO or WELL or GMRE or VTR or CHCT?

By revenue growth (latest reported year), Welltower Inc.

(WELL) is pulling ahead at 35. 8% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — GYRO or WELL or GMRE or VTR or CHCT?

Welltower Inc.

(WELL) is the more profitable company, earning 8. 8% net margin versus 0. 0% for Gyrodyne, LLC — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GMRE leads at 23. 6% versus -1. 2% for GYRO. At the gross margin level — before operating expenses — GYRO leads at 99. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is GYRO or WELL or GMRE or VTR or CHCT more undervalued right now?

On forward earnings alone, Community Healthcare Trust Incorporated (CHCT) trades at 37.

6x forward P/E versus 595. 7x for Global Medical REIT Inc. — 558. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.

08

Which pays a better dividend — GYRO or WELL or GMRE or VTR or CHCT?

In this comparison, GMRE (63.

5% yield), CHCT (11. 3% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. GYRO does not pay a meaningful dividend and should not be held primarily for income.

09

Is GYRO or WELL or GMRE or VTR or CHCT better for a retirement portfolio?

For long-horizon retirement investors, Ventas, Inc.

(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +65. 0%, GYRO: -31. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between GYRO and WELL and GMRE and VTR and CHCT?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: GYRO is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock; GMRE is a small-cap income-oriented stock; VTR is a mid-cap high-growth stock; CHCT is a small-cap income-oriented stock. WELL, GMRE, VTR, CHCT pay a dividend while GYRO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

GYRO

Quality Business

  • Sector: Real Estate
  • Market Cap > $100B
  • Gross Margin > 59%
Run This Screen
Stocks Like

WELL

High-Growth Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Net Margin > 7%
Run This Screen
Stocks Like

GMRE

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Gross Margin > 41%
Run This Screen
Stocks Like

VTR

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

CHCT

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Gross Margin > 37%
  • Dividend Yield > 4.5%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.